Articles

Low Vitamin D Levels Linked to Cancer Progression and Death in CLL Patients

Patients with chronic lymphocytic leukemia (CLL) who have insufficient levels of vitamin D at the time of diagnosis are at greater risk of cancer progression and death than patients with adequate levels, Mayo Clinic researchers have found.

TOP - Daily

A large National Cancer Institute (NCI)–sponsored study has shown for the first time that a screening method can reduce deaths from lung cancer by detecting cancers at relatively early stages.

TOP - Daily

Use of aspirin or other anticoagulants in addition to radiation therapy or surgery may reduce the risk of dying of prostate cancer by more than half, according to a large study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology.

TOP - Daily

Treatment with a combination of hormone therapy and radiation therapy (RT) improves overall and disease-specific survival in men with locally advanced prostate cancer compared with hormone therapy alone, according to interim results of a study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology.

Web Exclusives

Western Lifestyle Responsible for UK Breast Cancer Surge LONDON—A Western lifestyle characterized by an excess of food and alcohol and a lack of exercise may explain increasing breast cancer rates in the United Kingdom, new data suggest.

Findings from the World Cancer Research Fund (WCRF) show that the breast cancer rate in the United Kingdom is more than four times higher than in eastern Africa, which has the lowest breast cancer rate worldwide.

How to Keep Your Money Earning Interest

Web Exclusives

As the economy slowly recovers from the financial crisis, you may be looking for ways to boost the minuscule interest payments you are earning on your money. Although many different options and strategies for increasing your income stream are available, they may not be appropriate for your situation. Before making any decisions, do research and shop around for the best rates.

TOP - Daily

Adding chemotherapy to radiotherapy (RT) for muscle-invasive bladder cancer is well tolerated and improves loco-regional disease-free survival (LRDFS) compared with RT alone, according to a study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

TOP - Daily

The US Food and Drug Administration (FDA) has approved dasatinib (Sprycel, Bristol-Myers Squibb) 100 mg once daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

TOP - Daily

A study by Virginia Commonwealth University Massey Cancer Center researchers showed that most terminally ill cancer patients who were eligible for genetic testing did not receive it even though it could potentially save a relative's life.

The research, reported by John M. Quillin, PhD, and associates in the October issue of the Journal of Genetic Counseling, is the first to document the prevalence of hereditary cancer risk and the need for genetic services and patient education among terminally ill cancer patients.

TOP - Daily

Patients with metastatic colorectal cancer (CRC) who have KRAS –mutated tumors are currently excluded from treatment with the antiepidermal growth factor monoclonal antibodies cetuximab and panitumumab. A new study, however, suggests that patients with a KRAS codon 13 mutation have better outcomes when treated with cetuximab than patients with other KRAS mutations.

Articles

Page 269 of 288